NLRP3 and Parkinson disease: Similarly, activation of the NLRP3 inflammasome and subsequent GSDMD cleavage have been observed in the microglia of amyotrophic lateral sclerosis (ALS) patients and in Parkinson’s disease (PD) mouse models [53, 62].